MBH Corporation Plc
Revenues up by 81% to £49.6 million in first half of 2021
EBIT increase by 271% to £3.0 million vs first half of 2020
MBH Corporation now comprises 25 companies across 8 verticals
LONDON, UK / ACCESSWIRE / September 30, 2021 / The Directors of MBH Corporation PLC ("MBH") (OTCQX:MBHCF)(FRA:M8H), a diversified investment holding company, are pleased to release the results for the half year ended 30 June 2021, highlighting the continued success of the Company's growth and diversification strategy.
For the half-year period, the Company achieved revenue growth of 81% to £49.6 million (1H 2020: £27.4million) and a net profit after tax of £1.9 million. Earnings before interest and taxes ("EBIT") increased by 271% to £3.0 million (1H 2020: £0.8 million). The financial figures include the results of 4 companies acquired in 1H 2021, 3k Engineering, Boulder Sausage, 4X Taxis and Intercity Taxis.
Callum Laing, CEO, MBH Corporation PLC : "We are pleased to deliver this strong half-year report and solid growth in both revenue and EBIT. Although various pandemic related lockdowns and restrictions are still in place for the Group's Antipodean and Asian companies, it is worth noting that more than 60% of the revenue and 90% of the EBIT of the Group occurred from April onwards. A telling example of the power of the Group to generate revenue and profits as we slowly emerge from the global pandemic situation"
Solid financial position
The balance sheet of the Group remains strong with a net asset position of £62.7 million as of 30 June 2021. By comparison, as of 31 December 2020 the net asset position was £59.8 million. The net cash position (which includes bank overdrafts) for the first 6 months of 2021 was £6.3 million, an increase of £0.5 million from 31 December 2020. Cash generated from operating activities for 1H2021 was £3.8 million. The total number of shares outstanding as at 30 June 2021 was 73,681,548.
Callum Laing adds: "Year to date we have announced 5 further acquisitions for the Group: 3Ks Engineering, Boulder Sausage, 4X Limited Taxis, InterCity Taxis and VistaCare. We are cautiously optimistic that our businesses have regained some momentum and believe that despite ongoing challenges our companies are well equipped to keep delivering services to their clients and positive results to all our shareholders"
The complete 2021 half-year report is available on the Group's website at www.mbhcorporation.com/financial- half-year-report-2021
Webinar 'Meet the Principals':
Join all our Principals on 21st October 2021, 3.00pm GMT [UK], to hear how they have performed over the last six months. Please register in advance for this webinar here:
www.eventbrite.co.uk/e/live-principals-event-tickets-175846711247
Ends/
Contacts for IR and media enquiries:
- MBH Corporation plc, Charlotte Williams, charlotte@unity-group.com, +44 (0)770 396 3953
- Perception A, Phil Anderson & Charlie Nelson, phil@perceptiona.com, +44 (0)776 749 1519
About MBH
MBH Corporation plc (M8H:GR) is a diversified investment holding company, listed on the Frankfurt and Dusseldorf Stock Exchanges and the OTCQX in New York (MBHCF). The company acquires small to medium enterprises across multiple geographies and sectors that are well established, profitable and looking to scale. By leveraging the Agglomeration strategy, MBH Corporation plc is able to create substantial shareholder value through the consistent and accretive acquisition of excellent companies.
SOURCE: MBH Corporation Plc
View source version on accesswire.com:
https://www.accesswire.com/666223/MBH-Corporation-PLC-Builds-Significantly-on-2020-with-Growth-in-Revenue-of-81-in-First-Half-of-2021
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Karbon-X Celebrates Major Milestone in Senegal Mangrove Restoration Project28.10.2025 13:00:00 CET | Press release
Planting completed across 7,000 hectares in partnership with Woodside Energy, advancing community-led climate action. DAKAR, SN / ACCESS Newswire / October 28, 2025 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company") is proud to announce a significant milestone in its ABC Mangrove Project, one of West Africa's largest community-led restoration initiatives with the successful completion of planting across more than 7,000 hectares of mangroves along Senegal's coastline. Developed through ALLCOT, Karbon-X's project development and advisory arm (ALLCOT-A Karbon-X Company), and in partnership with Woodside Energy, the project is helping restore critical blue-carbon ecosystems that protect biodiversity, strengthen local economies, and capture carbon naturally from the atmosphere. Through this multi-year effort, thousands of local community members have been engaged in the planting and care of mangroves, creating new jobs, skills training, and sustainable income opportunities for wome
Florence Healthcare Launches SiteLink on AWS Marketplace, Extending its Clinical Trial Operations Platform Capabilities to Cloud28.10.2025 13:00:00 CET | Press release
ATLANTA, GEORGIA / ACCESS Newswire / October 28, 2025 / Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors and research sites worldwide, announced today that SiteLink, a key offering of Florence's Trial Operations Platform, is now available in AWS Marketplace. SiteLink accelerates study startup and enables real-time document distribution, monitoring, and data exchange with study sites, addressing the critical digital divide in clinical trials. With only 30% of global research sites currently using digital workflows, SiteLink helps bridge this gap by automating sponsor-site operational workflows. Bringing the Florence Trial Operations Platform Benefits to AWS As a core component of Florence's Trial Operations Platform, SiteLink delivers the same proven results that have made Florence the #1 clinical trial management solution for six consecutive years. The platform enables: Faster Startup: Up to 70% faster study activation timelines through automa
GoodData Brings AI-Native Data Intelligence to Financial Services28.10.2025 10:00:00 CET | Press release
Embeddable, compliant, and auditable AI agents unlock trusted automation for banks, insurers, and financial institutions. SAN FRANCISCO, CA / ACCESS Newswire / October 28, 2025 / GoodData, a leading analytics and data intelligence company, today unveiled new finance-focused applications for its composable AI platform, designed to tackle the industry's toughest challenges. By combining its AI Lake, AI Hub, and AI Apps into a single foundation for enterprise data intelligence, the next-generation platform gives financial institutions powerful tools to build and deploy AI agents. These agents can detect and investigate fraud in seconds with audit trails regulators can trust, keeping portfolios compliant in real time within industry guidelines. This streamlines regulatory reporting by compiling, checking, and submitting disclosures transparently, all while meeting strict standards for financial compliance, governance, and security. Purpose-built for finance The financial services sector fa
Cambridge Isotope Laboratories, Inc. Unveils ISOAPI-D - a New Standard in Deuterated Reagents for Pharmaceutical Innovation - at CPhI Frankfurt 202527.10.2025 14:00:00 CET | Press release
With ISOAPI-D, CIL offers pharmaceutical partners a secure, global supply of deuterated reagents - manufactured to the highest quality standards for faster, more efficient API development. TEWKSBURY, MASSACHUSETTS / ACCESS Newswire / October 27, 2025 / Cambridge Isotope Laboratories, Inc. (CIL), a global leader in stable isotope chemistry, announces the launch of ISOAPI-D™, a unified brand of deuterated intermediates for API synthesis. The new ISOAPI-D brand will be launched at CPhI Frankfurt, where CIL welcomes industry professionals to stand #2.0G2 from October 28-30.ISOAPI-D ISOAPI-D Power of Deuterium: Smarter, Stronger Therapeutics "ISOAPI-D reagents are designed to support the development of next-generation active pharmaceutical ingredients (APIs) by leveraging the unique benefits of deuterium incorporation," said Cliff Caldwell, CEO of CIL. "With ISOAPI-D, our customers gain access to a trusted and secure supply chain, ensuring they have consistent, reliable access to the materi
Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India27.10.2025 13:45:00 CET | Press release
Strategic Partnership to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad's Genome Valley, Enhancing Global Production and Supply of Isotopically Enriched Chemical Solutions for Pharmaceutical and Electronics Industries TEWKSBURY, MA AND HYDERABAD, INDIA / ACCESS Newswire / October 27, 2025 / Cambridge Isotope Laboratories, Inc. (CIL), and Chemtatva Chiral Solutions, Pvt. Ltd. (CCS), a leading provider of chiral and specialty chemical solutions, announce the execution of a signed Memorandum of Understanding to establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India. This initiative marks a milestone in the expansion of CIL's global footprint and further enhances capabilities in the development and production of deuterated reagents and other isotopically enriched products. This partnership will enhance global supply chain strength and real-time support for customers in Asia and enable multi-site production for global customers focused on business continui
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom